» Articles » PMID: 23292636

TargetHunter: an in Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database

Overview
Journal AAPS J
Specialty Pharmacology
Date 2013 Jan 8
PMID 23292636
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Target identification of the known bioactive compounds and novel synthetic analogs is a very important research field in medicinal chemistry, biochemistry, and pharmacology. It is also a challenging and costly step towards chemical biology and phenotypic screening. In silico identification of potential biological targets for chemical compounds offers an alternative avenue for the exploration of ligand-target interactions and biochemical mechanisms, as well as for investigation of drug repurposing. Computational target fishing mines biologically annotated chemical databases and then maps compound structures into chemogenomical space in order to predict the biological targets. We summarize the recent advances and applications in computational target fishing, such as chemical similarity searching, data mining/machine learning, panel docking, and the bioactivity spectral analysis for target identification. We then described in detail a new web-based target prediction tool, TargetHunter (http://www.cbligand.org/TargetHunter). This web portal implements a novel in silico target prediction algorithm, the Targets Associated with its MOst SImilar Counterparts, by exploring the largest chemogenomical databases, ChEMBL. Prediction accuracy reached 91.1% from the top 3 guesses on a subset of high-potency compounds from the ChEMBL database, which outperformed a published algorithm, multiple-category models. TargetHunter also features an embedded geography tool, BioassayGeoMap, developed to allow the user easily to search for potential collaborators that can experimentally validate the predicted biological target(s) or off target(s). TargetHunter therefore provides a promising alternative to bridge the knowledge gap between biology and chemistry, and significantly boost the productivity of chemogenomics researchers for in silico drug design and discovery.

Citing Articles

Fifteen years of ChEMBL and its role in cheminformatics and drug discovery.

Zdrazil B J Cheminform. 2025; 17(1):32.

PMID: 40065463 PMC: 11895189. DOI: 10.1186/s13321-025-00963-z.


Virtual screening: hope, hype, and the fine line in between.

Nada H, Meanwell N, Gabr M Expert Opin Drug Discov. 2025; 20(2):145-162.

PMID: 39862145 PMC: 11844436. DOI: 10.1080/17460441.2025.2458666.


Network pharmacology-integrated molecular modeling analysis of L. (agarwood) essential oil phytocompounds.

Jayaprakash P, Begum T, Lal M In Silico Pharmacol. 2024; 13(1):3.

PMID: 39726902 PMC: 11668724. DOI: 10.1007/s40203-024-00289-y.


CACTI: an in silico chemical analysis tool through the integration of chemogenomic data and clustering analysis.

Godinez-Macias K, Winzeler E J Cheminform. 2024; 16(1):84.

PMID: 39049122 PMC: 11270953. DOI: 10.1186/s13321-024-00885-2.


Putative mechanism of a multivitamin treatment against insulin resistance.

Palma-Jacinto J, Lopez-Lopez E, Medina-Franco J, Montero-Ruiz O, Santiago-Roque I Adipocyte. 2024; 13(1):2369777.

PMID: 38937879 PMC: 11216102. DOI: 10.1080/21623945.2024.2369777.


References
1.
Blair W, Cao J, Jackson L, Jimenez J, Peng Q, Wu H . Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing. Antimicrob Agents Chemother. 2007; 51(10):3554-61. PMC: 2043256. DOI: 10.1128/AAC.00643-07. View

2.
Keiser M, Setola V, Irwin J, Laggner C, Abbas A, Hufeisen S . Predicting new molecular targets for known drugs. Nature. 2009; 462(7270):175-81. PMC: 2784146. DOI: 10.1038/nature08506. View

3.
Bozkurt T, Sahin-Erdemli I . M(1) and M(3) muscarinic receptors are involved in the release of urinary bladder-derived relaxant factor. Pharmacol Res. 2009; 59(5):300-5. DOI: 10.1016/j.phrs.2009.01.013. View

4.
Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M . Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology. 2008; 135(4):1358-1368, 1368.e1-4. DOI: 10.1053/j.gastro.2008.06.082. View

5.
Patterson D, Cramer R, Ferguson A, Clark R, WEINBERGER L . Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. J Med Chem. 1996; 39(16):3049-59. DOI: 10.1021/jm960290n. View